Trial intelligence / Profile preview

Spironolactone versus placebo in acute central serous chorio-retinopathy

IRCT2016051627882N1Phase 4Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Aug 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in Central Serous Chorioretinopathy (CSCR) comparing spironolactone with placebo (2 arms). Started Aug 2015; status: completed.

02

Drugs

spironolactone
03

Conditions

Central Serous Chorioretinopathy (CSCR)

Beyond the preview

Go deeper on IRCT2016051627882N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016051627882N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call